Prenatal and Newborn Genetic Screening and Testing Market Analysis & Forecasts - ResearchAndMarkets.com

July 11, 2018

DUBLIN--(BUSINESS WIRE)--Jul 11, 2018--The “Prenatal and Newborn Genetic Screening and Testing Markets (by Application [Carrier Testing, Prenatal Screening, Newborn Testing, Newborn Screening], by Type [Services, Kits] by Geographic Region)” report has been added to ResearchAndMarkets.com’s offering.

The prenatal and newborn genetic screening and diagnostic testing market has already become a significant market, and it continues to grow - driven by several major factors. The number of genetic tests continues to grow. While many discoveries have been made about the causes of genetic disorders, there remains much more to learn before many of these discoveries can be used as clinical tests - but progress is also being made on this front. While potential causes of inherited disorders are still often evaluated on a gene by gene basis, technology advances such as chromosomal microarrays and DNA sequencing are making it possible to test panels to detect mutations associated with many different disorders in a single test.

Within the prenatal and newborn genetic screening market, non-invasive prenatal testing (NIPT) is driving the market. Much of the focus and attention in recent years has been on the emergence and growing use of complex LDTs based on technologies such as polymerase chain reaction (PCR), microarrays, next generation sequencing, or other complex technology.

A growing number of genetic tests has been made possible by advances in technology, including advances in chromosomal analysis - from traditional karyotyping to fluorescence in situ hybridization (FISH), and then to chromosomal microarrays and next generation sequencing. Detection of single gene mutations has been made possible with FISH and polymerase chain reaction (PCR) technology and is moving into even new possibilities with sequencing-based tests that can evaluate large numbers of genes simultaneously.

Companies Mentioned

Abbott Laboratories Affymetrix, Inc. Agilent, Inc Berry Genomics Co. Ltd. BGI Diagnostics Bio-Rad Laboratories Inc. Combimatrix Coopergenomics Counsyl Genepeeks, Inc. Genetadi Biotech S.L. Genoma Group Illumina, Inc. Innovations Exchange Pte Ltd and Igene Diagnostics Pte Ltd Laboratory Corporation of America LifeCodexx Ag Natera, Inc. Oxford Gene Technology Perkin Elmer Premaitha Health Quest Diagnostics Ravgen Reproductive Genetics Innovations Roche Diagnostic Corporation Sequenom, Inc. Thermo Fisher Scientific

Key Topics Covered:

1. Executive Summary

2. Introduction

3. Prenatal and Newborn Genetic Testing Market by Type

4. Selected Inherited Disorders

5. Prenatal and Newborn Screening and Diagnostic Testing Market

6. Market Drivers and Challenges - Prenatal and Newborn Genetic Screening and Diagnostic Testing

7. Market Analysis

8. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/v4sg5d/prenatal_and?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180711005330/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Diagnostics,Women’s Health,Maternal and Neonatal Care



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/11/2018 05:25 AM/DISC: 07/11/2018 05:25 AM


Update hourly